We propose to reinterpret a standard discriminative classifier of p(y|x) as an energy based model for the joint distribution p(x, y). In this setting, the standard class probabilities can be easily computed as well as unnormalized values of p(x) and p(x|y). Within this framework, standard discriminative architectures may be used and the model can also be trained on unlabeled data. We demonstrate that energy based training of the joint distribution improves calibration, robustness, and out-of-distribution detection while also enabling our models to generate samples rivaling the quality of recent GAN approaches. We improve upon recently proposed techniques for scaling up the training of energy based models and present an approach which adds little overhead compared to standard classification training. Our approach is the first to achieve performance rivaling the state-of-the-art in both generative and discriminative learning within one hybrid model.
Traditionally, precision medicine involves classifying patients to identify subpopulations that respond favorably to specific therapeutics. We pose precision medicine as a dynamic feedback control problem, where treatment administered to a patient is guided by measurements taken during the course of treatment. We consider sepsis, a life-threatening condition in which dysregulation of the immune system causes tissue damage. We leverage an existing simulation of the innate immune response to infection and apply deep reinforcement learning (DRL) to discover an adaptive personalized treatment policy that specifies effective multicytokine therapy to simulated sepsis patients based on systemic measurements. The learned policy achieves a dramatic reduction in mortality rate over a set of 500 simulated patients relative to standalone antibiotic therapy. Advantages of our approach are threefold: (1) the use of simulation allows exploring therapeutic strategies beyond clinical practice and available data, (2) advances in DRL accommodate learning complex therapeutic strategies for complex biological systems, and (3) optimized treatments respond to a patient's individual disease progression over time, therefore, capturing both differences across patients and the inherent randomness of disease progression within a single patient. We hope that this work motivates both considering adaptive personalized multicytokine mediation therapy for sepsis and exploiting simulation with DRL for precision medicine more broadly.
Generative probabilistic models of biological sequences have widespread existing and potential applications in analyzing, predicting and designing proteins, RNA and genomes. To test the predictions of such a model experimentally, the standard approach is to draw samples, and then synthesize each sample individually in the laboratory. However, often orders of magnitude more sequences can be experimentally assayed than can affordably be synthesized individually. In this article, we propose instead to use stochastic synthesis methods, such as mixed nucleotides or trimers. We describe a black-box algorithm for optimizing stochastic synthesis protocols to produce approximate samples from any target generative model. We establish theoretical bounds on the method’s performance, and validate it in simulation using held-out sequence-to-function predictors trained on real experimental data. We show that using optimized stochastic synthesis protocols in place of individual synthesis can increase the number of hits in protein engineering efforts by orders of magnitude, e.g. from zero to a thousand.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.